N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine

C131H161ClFN21 — CID 158235838

IUPACN-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine
SMILESCCn1c(C#CCNc2ccc(C)cc2)cc2cc(CNC3CCN(C)CC3)ccc21.CCn1c(C#CCNc2ccc(Cl)cc2)cc2cc(CNC3CCN(C)CC3)ccc21.CCn1c(C#CCNc2ccc(F)cc2)cc2cc(CNC3CCN(C)CC3)ccc21.CCn1c(C#CCNc2ccccc2)cc2cc(CNC3CCN(C)CC3)ccc21.CCn1c(C#CCNc2ccnc(C)c2)cc2cc(CNC3CCN(C)CC3)ccc21
InChIInChI=1S/C27H34N4.C26H31ClN4.C26H31FN4.C26H33N5.C26H32N4/c1-4-31-26(6-5-15-28-24-10-7-21(2)8-11-24)19-23-18-22(9-12-27(23)31)20-29-25-13-16-30(3)17-14-25;2*1-3-31-25(5-4-14-28-23-9-7-22(27)8-10-23)18-21-17-20(6-11-26(21)31)19-29-24-12-15-30(2)16-13-24;1-4-31-25(6-5-12-28-24-9-13-27-20(2)16-24)18-22-17-21(7-8-26(22)31)19-29-23-10-14-30(3)15-11-23;1-3-30-25(10-7-15-27-23-8-5-4-6-9-23)19-22-18-21(11-12-26(22)30)20-28-24-13-16-29(2)17-14-24/h7-12,18-19,25,28-29H,4,13-17,20H2,1-3H3;2*6-11,17-18,24,28-29H,3,12-16,19H2,1-2H3;7-9,13,16-18,23,29H,4,10-12,14-15,19H2,1-3H3,(H,27,28);4-6,8-9,11-12,18-19,24,27-28H,3,13-17,20H2,1-2H3
InChIKeyGEYINPBXWWCOIN-UHFFFAOYSA-N
MW2084.33 g/mol
LogP22.35
Rot. Bonds30

About N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine

N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine (PubChem CID 158235838) has the molecular formula C131H161ClFN21 and a molecular weight of 2084.33 g/mol. Its IUPAC name is N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine.

Molecular Properties

Compound NameN-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine
PubChem CID158235838
Molecular FormulaC131H161ClFN21
Molecular Weight2084.33 g/mol
Exact Mass2082.29
IUPAC NameN-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine
SMILESCCn1c(C#CCNc2ccc(C)cc2)cc2cc(CNC3CCN(C)CC3)ccc21.CCn1c(C#CCNc2ccc(Cl)cc2)cc2cc(CNC3CCN(C)CC3)ccc21.CCn1c(C#CCNc2ccc(F)cc2)cc2cc(CNC3CCN(C)CC3)ccc21.CCn1c(C#CCNc2ccccc2)cc2cc(CNC3CCN(C)CC3)ccc21.CCn1c(C#CCNc2ccnc(C)c2)cc2cc(CNC3CCN(C)CC3)ccc21
InChIInChI=1S/C27H34N4.C26H31ClN4.C26H31FN4.C26H33N5.C26H32N4/c1-4-31-26(6-5-15-28-24-10-7-21(2)8-11-24)19-23-18-22(9-12-27(23)31)20-29-25-13-16-30(3)17-14-25;2*1-3-31-25(5-4-14-28-23-9-7-22(27)8-10-23)18-21-17-20(6-11-26(21)31)19-29-24-12-15-30(2)16-13-24;1-4-31-25(6-5-12-28-24-9-13-27-20(2)16-24)18-22-17-21(7-8-26(22)31)19-29-23-10-14-30(3)15-11-23;1-3-30-25(10-7-15-27-23-8-5-4-6-9-23)19-22-18-21(11-12-26(22)30)20-28-24-13-16-29(2)17-14-24/h7-12,18-19,25,28-29H,4,13-17,20H2,1-3H3;2*6-11,17-18,24,28-29H,3,12-16,19H2,1-2H3;7-9,13,16-18,23,29H,4,10-12,14-15,19H2,1-3H3,(H,27,28);4-6,8-9,11-12,18-19,24,27-28H,3,13-17,20H2,1-2H3
InChIKeyGEYINPBXWWCOIN-UHFFFAOYSA-N
XLogP22.35
TPSA174.04 Ų
H-Bond Donors10
H-Bond Acceptors21
Rotatable Bonds30
Heavy Atoms154
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002084.33
LogP ≤ 522.35
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine?
The IUPAC name of N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine (CID 158235838) is N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine.
What is the SMILES notation for N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine?
The canonical SMILES for N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine is CCn1c(C#CCNc2ccc(C)cc2)cc2cc(CNC3CCN(C)CC3)ccc21.CCn1c(C#CCNc2ccc(Cl)cc2)cc2cc(CNC3CCN(C)CC3)ccc21.CCn1c(C#CCNc2ccc(F)cc2)cc2cc(CNC3CCN(C)CC3)ccc21.CCn1c(C#CCNc2ccccc2)cc2cc(CNC3CCN(C)CC3)ccc21.CCn1c(C#CCNc2ccnc(C)c2)cc2cc(CNC3CCN(C)CC3)ccc21.
What is the InChIKey of N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine?
The InChIKey is GEYINPBXWWCOIN-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H34N4.C26H31ClN4.C26H31FN4.C26H33N5.C26H32N4/c1-4-31-26(6-5-15-28-24-10-7-21(2)8-11-24)19-23-18-22(9-12-27(23)31)20-29-25-13-16-30(3)17-14-25;2*1-3-31-25(5-4-14-28-23-9-7-22(27)8-10-23)18-21-17-20(6-11-26(21)31)19-29-24-12-15-30(2)16-13-24;1-4-31-25(6-5-12-28-24-9-13-27-20(2)16-24)18-22-17-21(7-8-26(22)31)19-29-23-10-14-30(3)15-11-23;1-3-30-25(10-7-15-27-23-8-5-4-6-9-23)19-22-18-21(11-12-26(22)30)20-28-24-13-16-29(2)17-14-24/h7-12,18-19,25,28-29H,4,13-17,20H2,1-3H3;2*6-11,17-18,24,28-29H,3,12-16,19H2,1-2H3;7-9,13,16-18,23,29H,4,10-12,14-15,19H2,1-3H3,(H,27,28);4-6,8-9,11-12,18-19,24,27-28H,3,13-17,20H2,1-2H3.
What are the key properties of N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine?
N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine has a molecular weight of 2084.33 g/mol, XLogP of 22.35, 30 rotatable bonds, 10 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[2-(3-anilinoprop-1-ynyl)-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[2-[3-(4-chloroanilino)prop-1-ynyl]-1-ethylindol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-fluoroanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[[1-ethyl-2-[3-(4-methylanilino)prop-1-ynyl]indol-5-yl]methyl]-1-methylpiperidin-4-amine;N-[3-[1-ethyl-5-[[(1-methylpiperidin-4-yl)amino]methyl]indol-2-yl]prop-2-ynyl]-2-methylpyridin-4-amine is sourced from PubChem (CID 158235838), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).